METRONIDAZOLE
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB00916 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 17 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | endometritis | TxGNN Knowledge Graph |
| 2 | subacute bacterial endocarditis | TxGNN Knowledge Graph |
| 3 | giardiasis | TxGNN Knowledge Graph |
| 4 | vulvitis | TxGNN Knowledge Graph |
| 5 | arthropathy | TxGNN Knowledge Graph |
| 6 | endocarditis | TxGNN Knowledge Graph |
| 7 | trichomoniasis | TxGNN Knowledge Graph |
| 8 | rosacea | TxGNN Knowledge Graph |
| 9 | peritonitis | TxGNN Knowledge Graph |
| 10 | intracranial abscess | TxGNN Knowledge Graph |
| 11 | bacterial arthritis | TxGNN Knowledge Graph |
| 12 | vaginitis (disease) | TxGNN Knowledge Graph |
| 13 | vulvovaginitis | TxGNN Knowledge Graph |
| 14 | Peptostreptococcus infectious disease | TxGNN Knowledge Graph |
| 15 | amoebiasis due to Entamoeba histolytica | TxGNN Knowledge Graph |
| 16 | bacterial vaginosis | TxGNN Knowledge Graph |
| 17 | anaerobic bacteria infectious disease | TxGNN Knowledge Graph |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.